Periodontitis and Inflammation
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Apr 2, 2021
Trial Information
Current as of June 03, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding periodontitis, a serious gum disease that can lead to tooth loss and other health issues. Researchers aim to identify specific biological markers that reflect how the disease is affecting the body. By studying samples from people with advanced periodontitis and those with healthy gums, the trial hopes to uncover important information about the disease's causes and how it impacts overall health. The findings could help improve prevention and treatment strategies for periodontitis.
To be eligible for this study, participants must be at least 18 years old, speak and understand French, and agree to take part. They will either be individuals diagnosed with stage 3 or 4 periodontitis or those with healthy gums needing certain dental procedures. Participants can expect to provide biological samples, such as saliva and gum tissue, which will be collected before and during their treatment. It's important to note that individuals who have recently taken antibiotics or are pregnant cannot participate. This trial could lead to better understanding and treatment of gum disease, benefiting many people in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Common criteria for all patient groups
- • Patient \> 18 years old
- • Patient affiliated to a social security system, beneficiary or beneficiary of a right other than AME
- • Patient who speaks and understands French well enough to be able to read and understand the study information note.
- • Patient who does not object to his participation in the study
- Specific criteria:
- • - Case Periodontitis: Patient with localized or generalized periodontitis, stage 3 or 4. The diagnosis of periodontitis is based on the elements found during the interview and clinical examination
- • - Case peri-implantitis: Patients with at least 1 implant affected by peri-implantitis. Diagnosis is based on the findings of the interview, clinical examination and radiographic examination.
- Control group:
- • Patient with gingival health on intact or reduced periodontium with no history of periodontitis or peri-implantitis and requiring surgical care such as dental avulsion and pre-prosthetic periodontal corrective/aesthetic surgeries (coronal elongation, neck alignment.)
- Exclusion Criteria:
- • Patients who have received antibiotic prophylaxis, antibiotic therapy, or anti-inflammatory treatment within 3 months prior to inclusion
- • Pregnant or breastfeeding women
- • Patient included in another interventional research protocol or in a period of exclusion.
- • Patients under guardianship, curatorship or legal protection.
- • Patient having expressed his opposition to participate in the research
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ivry Sur Seine, , France
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials